Brief: Terns Announces Pricing Of Upsized $650 Million Public Offering At $40 Per Share
Dec 9 (Reuters) - Terns Pharmaceuticals Inc TERN.O: TERNS ANNOUNCES PRICING OF UPSIZED $650 MILLION PUBLIC OFFERING TERNS PHARMACEUTICALS INC - PRICES UPSIZED OFFERING OF 16,250,000 SHARES AT $40.00 EACH Source text: ID:nGNX4bPcJt Further company coverage: TERN.O ((Reuters.briefs@thomsonreuters.com;))
Recent news on Terns Pharmaceuticals
See all newsNASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
U.S. RESEARCH ROUNDUP-East West Bancorp, Reliance, S&P Global
Brief: Merck Announces Expiration Of Hart-Scott-Rodino Act Waiting Period To Acquire Terns Pharmaceuticals
Brief: Merck Begins Tender Offer To Acquire Terns Pharmaceuticals, Inc.